title: Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.
authors.affiliation: Department of Medicine, Harvard Medical School, Boston, Massachusetts.
authors.forename: C H
authors.initials: CH
authors.lastname: Hennekens
authors.forename: J E
authors.initials: JE
authors.lastname: Buring
authors.forename: P
authors.initials: P
authors.lastname: Sandercock
authors.forename: R
authors.initials: R
authors.lastname: Collins
authors.forename: R
authors.initials: R
authors.lastname: Peto
mesh_terms: D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use*; D001696:Biomechanical Phenomena; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D009203:Myocardial Infarction / Q000517:prevention & control; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D012008:Recurrence; D012307:Risk Factors
chemical_list: D010975:Platelet Aggregation Inhibitors; D001241:Aspirin